The Vanderbilt Program in Drug Discovery is finding hope for children with the leading genetic cause of autism: Fragile X Syndrome. Listen to Jeff Conn, Ph.D., and his team, describe a change in how drugs are being discovered — making hope possible for these families for the first time.

Podcast produced by Carole Bartoo, R.N.
VUMC Office of News and Public Affairs